Type 2 diabetes monitoring system based on blood glucose monitoring and application in disease monitoring system

Abstract

This invention provides a type 2 diabetes monitoring system based on blood glucose monitoring, which comprises a real-time dynamic blood glucose monitoring device, a dynamic blood glucose monitoring workstation and a blood glucose intelligent analysis server. In combination with big data statistics, the type 2 diabetes monitoring system based on blood glucose monitoring presets a threshold group for judging blood glucose control situation, which corresponds to oral drug information or insulin injection information or insulin pump information, then a diagnostic analysis report of blood glucoseis generated by using the received user information and real-time blood glucose value according to preset rule, and the diagnostic analysis report of blood glucose is sent to the dynamic blood glucosemonitoring workstation to remind relevant personnel to make timely treatment and make intelligent and accurate analysis of blood glucose control in a long period, thereby providing good data supportfor subsequent blood glucose control. The type 2 diabetes monitoring system based on blood glucose monitoring has the advantages of being simple in structure and high in security. The invention further discloses an application of the type 2 diabetes monitoring system based on blood glucose monitoring in disease monitoring system.

Description

technical field [0001] The invention relates to the field of smart medical care, in particular to a type 2 diabetes monitoring system based on blood sugar monitoring and its application in the disease monitoring system. Background technique [0002] Type 2 diabetes, formerly known as adult-onset diabetes, usually occurs after the age of 35 to 40. The ability to produce insulin in patients with type 2 diabetes is not completely lost. Some patients even produce too much insulin, but the effect of insulin is poor. Therefore, the insulin in the patient's body is relatively deficient, and some oral drugs can be used to stimulate the secretion of insulin in the body. However, some patients still need to use insulin therapy in the later stage. Type 2 diabetes accounts for more than 90% of diabetic patients. At present, patients with type 2 diabetes need to go to the hospital for blood sugar monitoring regularly to understand the current blood sugar situation and judge the effect ...

AI Technical Summary

Problems solved by technology

[0002] Type 2 diabetes, formerly known as adult-onset diabetes, usually occurs after the age of 35 to 40. The ability to produce insulin in patients with type 2 diabetes is not completely lost. Some patients even produce too much insulin, but the effect of insulin is poor. Therefore, the insulin in the patient's body is relatively deficient, and some oral drugs can be used to stimulate the secretion of insulin in the body.

However, the blood sugar of patients with type 2 diabetes generally fluctuates greatly, and it is often difficult to truly reflect the real blood sugar level of the patient when they go to the hospital to measure the blood sugar level at a certain time point

If you increase the number of times you go to the hospital to monitor blood sugar, it will not only increase the trouble for the patient, but also bring a lot of repetitive workload to the medical staff, waste the energy of the patient and the medical staff, and increase the burden of medical expenses on the patient, the hospital, and the country.

Images